Masters of Pediatric Dermatology Symposium Poster Presentation: First in Human Phase 2 Trial of Zabalafin (AB-101) – Interim Results - Alphyn

Masters of Pediatric Dermatology Symposium Poster Presentation: First in Human Phase 2 Trial of Zabalafin (AB-101) – Interim Results

NEWS PROVIDED BY
Alphyn Biologics
February 8, 2023, 17:00 ET

Alphyn MOPD 2024 Poster Interim Results Final

CONTACTS

Corporate:
Neal Koller
nkoller@alphynbiologics.com
(410) 690-8687

Media:
Susan Thomas
susan@endpointcommunications.net
(619) 540-9195